Anthem Blue Cross Blue Shield of California prior authorization, page 62

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
J2277Motixafortide (Aphexda)California PPO Prior Authorization List, Pg 164 Original policy
J2787Riboflavin 5'-phosphate, ophthalmic solution, up to 3 mL [Photrexa, Photrexa Viscous]California PPO Prior Authorization List, Pg 164 Original policy
J2802Romiplostim (Nplate)California PPO Prior Authorization List, Pg 164 Original policy
J3055Talquetamab-tgvs (Talvey)California PPO Prior Authorization List, Pg 164 Original policy
J3263Toripalimab-tpzi (Loqtorzi)California PPO Prior Authorization List, Pg 164 Original policy
J3315Triptorelin pamoate (Trelstar, Trelstar Depot, Trelstar LA)California PPO Prior Authorization List, Pg 164 Original policy
J9286Glofitamab-gxbm (Columvi)California PPO Prior Authorization List, Pg 164 Original policy
J7330Autologous cultured chondrocytes, implantCalifornia PPO Prior Authorization List, Pg 164 Original policy
J9011Datopotamab deruxtecan‑dlnk (Datroway)California PPO Prior Authorization List, Pg 164 Original policy
J9015Aldesleukin (Proleukin)California PPO Prior Authorization List, Pg 164 Original policy
J9021Asparaginase erwinia chrysanthemi (recombinant)-rywn (Rylaze)California PPO Prior Authorization List, Pg 164 Original policy
J9022Atezolizumab (Tecentriq)California PPO Prior Authorization List, Pg 164 Original policy
J9023Avelumab (Bavencio)California PPO Prior Authorization List, Pg 164 Original policy
J9024Atezolizumab and hyaluronidase-tqjs (Tecentric Hybreza)California PPO Prior Authorization List, Pg 164 Original policy
J9028Nogapendekin alfa inbekicept-pmln (Anktiva)California PPO Prior Authorization List, Pg 164 Original policy
J9026Tarlatamab-dlle (Imdelltra)California PPO Prior Authorization List, Pg 164 Original policy
J9029Nadofaragene firadenovec-vncg (Adstiladrin)California PPO Prior Authorization List, Pg 164 Original policy
J9032Belinostat (Beleodaq)California PPO Prior Authorization List, Pg 165 Original policy
J9038Axatilmab-csfr (Niktimvo)California PPO Prior Authorization List, Pg 165 Original policy
J9039Blinatumomab (Blincyto)California PPO Prior Authorization List, Pg 165 Original policy
J9042Brentuximab vedotin (Adcetris)California PPO Prior Authorization List, Pg 165 Original policy
J9043Cabazitaxel (Jevtana)California PPO Prior Authorization List, Pg 165 Original policy
J9047Carfilzomib (Kyprolis)California PPO Prior Authorization List, Pg 165 Original policy
J9053Belantamab mafodotin-blmf (Blenrep)California PPO Prior Authorization List, Pg 165 Original policy
J9055Cetuximab (Erbitux)California PPO Prior Authorization List, Pg 165 Original policy
J9056Bendamustine (Vivimusta)California PPO Prior Authorization List, Pg 165 Original policy
J9057Copanlisib HCl (Aliqopa)California PPO Prior Authorization List, Pg 165 Original policy
J9061Amivantamab-ymoiw (Rybrevant)California PPO Prior Authorization List, Pg 165 Original policy
J9062Amivantamab and hyaluronidase-lpuj (Rybrevant Faspro)California PPO Prior Authorization List, Pg 165 Original policy
J9063Mirvetuximab (Elahere)California PPO Prior Authorization List, Pg 165 Original policy
J9064Cabazitaxel (Sandoz), not therapeutically equivalent to J9043California PPO Prior Authorization List, Pg 165 Original policy
J9118Calaspargase pegol-mknl (Asparlas)California PPO Prior Authorization List, Pg 165 Original policy
J9119Cemiplimab-rwlc (Libtayo)California PPO Prior Authorization List, Pg 165 Original policy
J9144Daratumumab, 10 mg and hyaluronidase-fih (Darzalex Faspro)California PPO Prior Authorization List, Pg 165 Original policy
J9145Daratumumab (Darzalex)California PPO Prior Authorization List, Pg 165 Original policy
J9161Denileukin diftitox-cxdl (Lymphir)California PPO Prior Authorization List, Pg 165 Original policy
J9173Durvalumab (Imfinzi)California PPO Prior Authorization List, Pg 166 Original policy
J9176Elotuzumab (Empliciti)California PPO Prior Authorization List, Pg 166 Original policy
J9177Enfortumab vedotin-ejfv (Padcev)California PPO Prior Authorization List, Pg 166 Original policy
J9179Eribulin mesylate (Halaven)California PPO Prior Authorization List, Pg 166 Original policy
J9183Gemcitabine intravescial system (Inlexzo)California PPO Prior Authorization List, Pg 166 Original policy
J9203Gemtuzumab ozogamicin (Mylotarg)California PPO Prior Authorization List, Pg 166 Original policy
J9207Ixabepilone (Ixempra)California PPO Prior Authorization List, Pg 166 Original policy
J9216Interferon Gamma-1b (Actimmune)California PPO Prior Authorization List, Pg 166 Original policy
J9223Sacituzumab govitecan-hziy, 10 mg (Zepzelca)California PPO Prior Authorization List, Pg 166 Original policy
J9227Injection, isatuximab-irfc, 10 mg (Sarclisa)California PPO Prior Authorization List, Pg 166 Original policy
J9228Ipilimumab (Yervoy)California PPO Prior Authorization List, Pg 166 Original policy
J9229Inotuzumab Ozogamicin (Besponsa)California PPO Prior Authorization List, Pg 166 Original policy
J9262Omacetaxine mepesuccinate (Synribo)California PPO Prior Authorization List, Pg 166 Original policy
J9264Paclitaxel protein-bound (Abraxane)California PPO Prior Authorization List, Pg 166 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.